It is a complicated problem. In Canada, we don't have the same problem that other countries are facing. We have other issues with access, but our insulin prices have not seen the same kind of skyrocketing increases that the United States, for example, or other places around the world have seen.
To be truthful, we don't completely know why this is happening. It is a multi-faceted issue. We are lacking a lot of transparency in terms of the way things are priced, which is a major issue. We don't know where along the supply chain these price increases are always happening.